catechin and E coli Infections

catechin has been researched along with E coli Infections in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Ayala-Zavala, JF; Bernal-Mercado, AT; Encinas-Basurto, D; Gonzalez-Aguilar, GA; Gutierrez-Pacheco, MM; Islas-Osuna, MA; Lopez-Zavala, AA; Mata-Haro, V1
Bhaskaran, S; Hari, N; Solomon, AP; Thamil Selvan, G; Vasudevan, S1
Hou, A; Li, K; Li, Z; Tian, X; Wang, Y; Xie, J1
Fan, S; Li, J; Li, W; Sama, AE; Tracey, KJ; Tsai, S; Wang, H; Wang, P; Zhao, L; Zhu, S1
Cho, YH; Ha, US; Han, CH; Kim, HW; Lee, CB; Lee, SJ; Sohn, DW; Yoon, BI1
Cho, YH; Han, CH; Kang, SH; Kim, SW; Lee, SJ; Lee, YS; Shin, OR; Sim, YC1
Isogai, E; Isogai, H; Nishikawa, T; Takeshi, K1
Hayashi, S; Hirose, K; Isogai, E; Isogai, H; Oguma, K1

Other Studies

8 other study(ies) available for catechin and E coli Infections

ArticleYear
Synergistic mode of action of catechin, vanillic and protocatechuic acids to inhibit the adhesion of uropathogenic Escherichia coli on silicone surfaces.
    Journal of applied microbiology, 2020, Volume: 128, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Catechin; Catheters; Drug Synergism; Escherichia coli Infections; Fimbriae, Bacterial; Humans; Hydroxybenzoates; Phenols; Silicones; Urinary Tract Infections; Uropathogenic Escherichia coli; Vanillic Acid

2020
Reciprocal Cooperation of Type A Procyanidin and Nitrofurantoin Against Multi-Drug Resistant (MDR) UPEC: A pH-Dependent Study.
    Frontiers in cellular and infection microbiology, 2020, Volume: 10

    Topics: Biflavonoids; Biofilms; Catechin; Escherichia coli Infections; Humans; Hydrogen-Ion Concentration; Nitrofurantoin; Pharmaceutical Preparations; Proanthocyanidins; Urinary Tract Infections; Uropathogenic Escherichia coli

2020
Proteomic changes in EHEC O157:H7 under catechin intervention.
    Microbial pathogenesis, 2018, Volume: 123

    Topics: Anti-Bacterial Agents; Bile Acids and Salts; Catechin; Escherichia coli Infections; Escherichia coli O157; Gastrointestinal Tract; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Proteome

2018
Green tea catechins quench the fluorescence of bacteria-conjugated Alexa fluor dyes.
    Inflammation & allergy drug targets, 2013, Volume: 12, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Catechin; Cells, Cultured; Coinfection; Escherichia coli; Escherichia coli Infections; Fluorescence; Humans; Hydrazines; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Organic Chemicals; Staphylococcal Infections; Staphylococcus aureus; Theaceae

2013
Anti-inflammatory and antimicrobial effects of nanocatechin in a chronic bacterial prostatitis rat model.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Catechin; Chronic Disease; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Humans; Male; Prostate; Prostatitis; Rats; Rats, Wistar

2011
Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model.
    International journal of urology : official journal of the Japanese Urological Association, 2005, Volume: 12, Issue:4

    Topics: Animals; Anti-Infective Agents; Catechin; Chronic Disease; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Follow-Up Studies; Male; Prostate; Prostatitis; Random Allocation; Rats; Rats, Wistar; Treatment Outcome; Urine

2005
Protective effect of Japanese green tea extract on gnotobiotic mice infected with an Escherichia coli O157:H7 strain.
    Microbiology and immunology, 1998, Volume: 42, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Catechin; Disease Models, Animal; Escherichia coli Infections; Escherichia coli O157; Female; Male; Mice; Tea

1998
In vivo synergy between green tea extract and levofloxacin against enterohemorrhagic Escherichia coli O157 infection.
    Current microbiology, 2001, Volume: 42, Issue:4

    Topics: Animals; Anti-Infective Agents; Catechin; Colony Count, Microbial; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Escherichia coli Infections; Escherichia coli O157; Feces; Female; Germ-Free Life; Levofloxacin; Male; Mice; Mice, Inbred ICR; Ofloxacin; Plant Extracts; Shiga Toxin; Tea

2001